NervGen Pharma Reports Q2 2024 Financial Results and Operational Updates
Go back to NervGen Pharma Reports Q2 2024 Financial Results and Operational Updates| (AMEX: NGENF) | Delayed: 5.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.84 | 52 Week High | $ | |||
| Open | $5.84 | 52 Week Low | $ | |||
| Day High | $5.84 | P/E | N/A | |||
| Day Low | $5.84 | EPS | $ | |||
| Volume | 904 | |||||

